| Synthesis of Triazole Derivatives of Levoglucosenone As Promising Anticancer Agents: Effective Exploration of the Chemical Space through retro-aza-Michael//aza … Y Tsai, CM Borini Etichetti, C Di Benedetto, JE Girardini, FT Martins, ... The Journal of Organic Chemistry 83 (7), 3516-3528, 2018 | 32 | 2018 |
| Dynamic regulation of Pin1 expression and function during zebrafish development MS Ibarra, C Borini Etichetti, C Di Benedetto, GL Rosano, E Margarit, ... PLoS One 12 (4), e0175939, 2017 | 27 | 2017 |
| Isoprenylcysteine carboxy methyltransferase (ICMT) is associated with tumor aggressiveness and its expression is controlled by the p53 tumor suppressor CB Etichetti, C Di Benedetto, C Rossi, MV Baglioni, S Bicciato, G Del Sal, ... Journal of Biological Chemistry 294 (13), 5060-5073, 2019 | 19 | 2019 |
| NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer C Di Benedetto, J Oh, Z Choudhery, W Shi, G Valdes, P Betancur BMC cancer 22 (1), 1056, 2022 | 9 | 2022 |
| High-resolution Inference of Multiplexed Anti-HIV Gene Editing using Single-Cell Targeted DNA Sequencing MS Bouzidi, ZY Dossani, C Di Benedetto, KA Raymond, S Desai, ... bioRxiv, 2024 | 1 | 2024 |
| Isoprenylcysteine carboxyl methyltransferase (ICMT) promotes invadopodia formation and metastasis in cancer cells CB Etichetti, EA Zalazar, C Di Benedetto, N Cocordano, S Valente, ... Biochimie 222, 28-36, 2024 | 1 | 2024 |
| The p53 tumor suppressor regulates AKR1B1 expression, a metastasis-promoting gene in breast cancer C Di Benedetto, C Borini Etichetti, N Cocordano, A Cantoia, ... Frontiers in Molecular Biosciences 10, 1145279, 2023 | 1 | 2023 |
| Enhancer clusters drive type I interferon-induced TRAIL overexpression in cancer, and its intracellular protein accumulation fails to induce apoptosis C Di Benedetto, T Khan, S Serrano-Saenz, A Rodriguez-Lemus, ... Cancers 15 (3), 967, 2023 | 1 | 2023 |
| Mecanismos moleculares de agresividad tumoral: rol de aldosa reductasa y su relación con la vía de p53 C Di Benedetto | | 2019 |
| Role of AKR1B1 in tumor aggressiveness and its interplay with the p53 pathway in breast cancer D Benedetto C, B Etichetti CM, B S, M Márquez M, G JE BIOCELL 42, 67, 2018 | | 2018 |
| Characterization of mutant p53-based molecular mechanisms of tumor aggressiveness GJE Di Benedetto C, Borini Etichetti C BIOCELL 39, 77, 2015 | | 2015 |
| Inhibition of proline-directed phosphorylation signaling as a potential antitumor strategy C Di Benedetto, L Paoletti, CE Banchio, JE Girardini BIOCELL 38, 102-103, 2014 | | 2014 |
